Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TODAY MAY 22
7-8 a.m.
Join via ZOOM
Meeting ID: 913 1277 5742
Tomorrow we are honored to host @EKNduom from @EmoryNeurosurg for #Neurosurgery #GrandRounds. Esteemed surgeon, scientist, #Advocate, and leader @CNS_Update, we are excited for his talk "New Approaches to Immune Therapy for #Glioblastoma: Lessons Learned". @GWSMHS #CancerMoonshot pic.twitter.com/pnFlB1j2fI
— George Washington Neurosurgery (@GWnsgy) May 21, 2024
At the tumor session with Dr. Liau and Dr. Lim! #AANS2024 @MichaelLimMD @UCLANsgy @IsaacYangMD @AANSNeuro @StanfordNsurg #WhatMatters2Me pic.twitter.com/h5mFIOSmGc
— The Yang Lab (@TheYangLab1) May 5, 2024
AANS2024 Chicago
Monday, May 6, 2024
11:06 AM – 11:26 AM CT
Location: S503ab
Linda Liau – Immunotherapy.
Congratulations to the stellar lineup of UCLA #Neurosurgery Faculty & Residents who are scheduled at the @AANSNeuro Annual Meeting this weekend! Schedule: https://t.co/y6CRiQe2fi@ausaf @geoffreycolbymd @SpineNeuro @inspired_brain @IsaacYangMD @ShivaniBaisi_MD @brainbro #AANS2024 pic.twitter.com/oQ8oHKHmyz
— UCLA Neurosurgery 🧠 (@UCLANsgy) May 1, 2024
FORM 10-K/A (Amendment No. 1) filed April 29: https://www.otcmarkets.com/filing/html?id=17489512&guid=d5Q-kqGyIgi7B3h
Last Friday, we were honored to have Dr. Linda Liau as our 42nd Annual J. Jay Keegan Lecturer. It was an extraordinary afternoon for our residents with a phenomenal presentation and dinner to follow. We are so indebted to Dr. Liau for her time here in #Omaha. @unmc @UCLANsgy pic.twitter.com/tqb36hpn6w
— UNMC Department of Neurosurgery (@UNMC_NeuroSurg) April 22, 2024
Calendar days and not business (working) days.
From MHRA:
Guidance
International Recognition Procedure - supplementary information
Updated 8 April 2024
Ex,
EAMS medicines are provided free of charge to the NHS (National Health Service),‘Specials’ may be provided free of charge or charged (generating revenue).
From inspire.com:
I hope Dr.Mulholland’s next immunotherapy trial for people with glioblastoma (this summer?) is a combo trial with DCVax-L.
Thank you @Siobhain_Mc for campaigning on this issue. It would be amazing to get Dr Mulholland’s #immunotherapy trial for people with #glioblastoma up and running this summer. We’re with you! https://t.co/YWoEuSQ1q9
— The National Brain Appeal (@BrainAppeal) April 3, 2024
Diagnosed with a glioblastoma, Matthew is raising funds to pay for DC Vax-L treatment, which has the potential to extend his life, but is not available on the NHS. Access to new and better treatments - #ItsANoBrainer. Sign our open letter today: https://t.co/yvQSBzL5ta pic.twitter.com/oT4Dz7YB1v
— The Brain Tumour Charity (@BrainTumourOrg) March 25, 2024
Interesting Gofundme story.
Bo’s Brain Cancer Treatment.
2 days ago.
Smokey, I wish you a full recovery! Stay strong and never give up!
Thanks for sharing the podcast ( Joe Miller discusses the “bombshell lawsuit,” spoofing, and high frequency trading practices)+transcript, hyperopia!
And thanks for the Bristol Meyers/Medarex story.
New peer-reviewed publication already accepted:
The case study may be about Owain James. The tumor is 14cm, only half of it can be removed, and three vaccines were made. But with the intense anti-tumor response, the remaining half shrank into cyst under continual pounding of the immune system. I suspect that in his case the… pic.twitter.com/gAajsAtAHF
— d_stock (@d_stock07734) March 5, 2024
Updates on Neoadjuvant Checkpoint Blockade Immunotherapy for Glioblastoma.
9th Annual Advances in Brain Tumor Management Course
Feb.9, 2024
Robert M.Prins, PhD
Min.1
Min.16.15s
Conquering Glioblastoma: A Tribute to Margaret McDonagh | Official Director's Cut (2024 Movie)
Remarks around min.16m.15s
Try this. I could read it for free.(+ comments)
‘Spoofing’ case might draw back curtain on high-speed trading firms like Citadel Securities - column by @JoeMillerJr https://t.co/0rwufVPmco
— Tony Tassell (@TonyTassell) March 2, 2024
Thanks sharpie510!
Prof. Keyoumars Ashkan:
"So honoured to have been part of this event. We cannot do enough to highlight the needs of our patients. Thank you The Brain Tumour Charity for advocating for our patients."
🧠✨ Today we stand with 34 community members to honour those diagnosed with brain tumours daily.
— The Brain Tumour Charity (@BrainTumourOrg) February 29, 2024
No more waiting for change. Improving brain tumour care is a No Brainer.
Sign our open letter 👉 https://t.co/mZR1JHoSg3#ItsANoBrainer #BrainTumourAwarenessMonth pic.twitter.com/psxcp6EGJ5
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) February 29, 2024
"Debate in the Commons on a motion to introduce the Brain Tumours Bill under the ten minute rule, with Labour MP Dame Siobhain McDonagh, from Wednesday 28 February"
"Dr Paul Mulholland - he believes we are on the cusp of a cure"https://t.co/cmEg97hgKC pic.twitter.com/FiP78ILH88
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) February 29, 2024
Full text of Brain Tumours bill
Volume 746: debated on Wednesday 28 February 2024
Dame Siobhain McDonagh
(Mitcham and Morden) (Lab)
Sharethis specific contribution
I beg to move,
That leave be given to bring in a Bill to set a target for the number of… pic.twitter.com/kIPYnav5I6
📜Today I passed my 10 Minute Rule Bill for the 3,200 people who are diagnosed with a glioblastoma brain tumour every single year...
— Siobhain McDonagh MP (@Siobhain_Mc) February 28, 2024
Thank you to @wesstreeting and @willquince for your cross party support pic.twitter.com/x4kepaGAD2
In a groundbreaking phase III clinical trial, DCVax-L, an innovative treatment, has exhibited the potential to significantly prolong the lives of individuals grappling with both new and recurrent glioblastoma.
— EndBrainCancer Initiative (@EndBrainCancer) February 22, 2024
Learn more at https://t.co/TUXwUta6wh#GBM #clinicaltrial pic.twitter.com/Nh37518NlR
Talk about implementing digital technologies in ATMPs Manufacturing.
Autolomous presentation around min 22.30:
https://iuk.ktn-uk.org/events/sme-showcase-digital-technologies-in-medicines-manufacturing/
Icon sign & design limited.
Feb.8,
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) February 12, 2024
Found this excellent video presentation by Linda Liau
from 2021 I personally have not seen before, organized by the Pakistan Society of Neuro-Oncology. Linda starts presenting at 47 mins with her slide deck starting at 49 mins. Linda presents on session 10.… pic.twitter.com/xytQnK3CX1
Hyperopia,
You may be interested in the upcoming instalment of the InnovateUK TMM CoP SME Showcase webinar series in which industry experts James Rutley (Autolomous) and Yatindra Tirunagari (Rentschler Biopharma SE) will delve into the many ways digital technologies are revolutionising the field of medicines manufacturing.
🗓️Date: Tuesday 13th of February
⏰Time: 10:00 AM - 11:00 AM GMT
🔗Register: https://rb.gy/vcybit
Expect deep dives into topics such as:
👉 The cutting-edge advancements in digital tools for advanced therapies
👉 How the successful implementation of such technologies can improve efficiency, scalability, and accessibility of these life-saving treatments
👉 Navigating the challenges and exciting opportunities associated with digital transformation.
Engage with the Innovate UK #TMMCoP and hear from funded SMEs on how digital technologies are shaping the future of medicines manufacturing.
— Innovate UK Business Connect (@IUK_Connect) February 2, 2024
Join us on 13 Feb at 10am
Register here> https://t.co/M4dzAuSWK9 #TransformingMedicinesManufacturing #DigitalTransformation pic.twitter.com/nuU7YgQmDq
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) February 9, 2024
Some quotes about submission of MAA to MHRA
Drew Hope - Senior GMP Compliance Consultant and Qualified Person
"Great hope for patients with glioblastoma and really exciting news for me and my colleagues as we progress towards marketing authorisation of this… pic.twitter.com/tqw4jdDcOV
Today IMO.
It is the last article posted on their website under the Research & Campaigning News section.
The penultimate article was posted on February 7 on the Brain Tumour Reseach blog.
The voices of more than 81,000 brain tumour campaigners were heard at Westminster this week when the brain tumour petition was handed in to @10DowningStreet – find out more in our campaigning update from @hugh1eadams
— Brain Tumour Research (@braintumourrsch) February 7, 2024
Read more ➡️ https://t.co/5OQzOnKMNf
#BrainTumourPetition pic.twitter.com/8UStjXK89n
Northwest Biotherapeutics announced earlier this year that they have applied to the MHRA for marketing approval for DCVax-L, a vaccine treatment for glioblastoma. Read more about how it could impact patients here ➡️ https://t.co/kPifp9AYss#Glioblastoma #dcvax #BrainTumour pic.twitter.com/fshhwIpUJn
— Brain Tumour Research (@braintumourrsch) February 10, 2024
On Feb. 5, 2024 Bill Malloy published an article about DCVax-L.
Vaccine May Extend Life Expectancy For People with Aggressive Brain Cancer.
by Bill Malloy | Feb 5, 2024 | Cancer, Medication, Pharmaceuticals
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) February 7, 2024